BioUtah News

American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health

RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11.…
Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies

Attostat is now EVŌQ Nano! The Utah start-up has a new name, a clean look and a fresh…
Novel Embolic Device Used for Arterial and Venous Tumor Treatments

Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block…
MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE

Last week, Salt Lake City (SLC) Mayor Erin Mendenhall gave her second State of the City address –…
Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer

Spectrum Solutions, LLC on January 27 announced it is sponsoring research in collaboration with the UCLA School of…
Entrepreneur Your Startup – Get a Master’s Degree

Calling all life sciences early stage founders and startups! In partnership with the Lassonde Entrepreneur Institute at the…
SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in…
Science and Safety of the COVID-19 Vaccine (January 15, 2021)

Presented by BioUtah and the Salt Lake Chamber on January 15, 2021, this webinar provided a briefing with biopharmaceutical…
Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products

Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly…
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited; Provides Corporate Update

Clene Nanomedicine, Inc. (Clene) last week announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”)…
Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression…
Early Vaccination Available for Some Life Science Industry Employees

We’ve received more information on channels for vaccine distribution with some positive developments

Call to Action

Experience Seamless Style and Speed

Explore More

American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health

Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies

Novel Embolic Device Used for Arterial and Venous Tumor Treatments

MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE

Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer

Entrepreneur Your Startup – Get a Master’s Degree

SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes

Science and Safety of the COVID-19 Vaccine (January 15, 2021)

Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products

Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited; Provides Corporate Update

Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

Early Vaccination Available for Some Life Science Industry Employees

Call to Action

Post Category

Latest Posts

Social Links

SPECIAL THANKS TO OUR LEGACY & PLATINUM ELITE MEMBERS